Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy
Condition:   Peanut Allergy Interventions:   Drug: Abatacept;   Other: Peanut oral immunotherapy Sponsors:   Philippe Bégin;   Centre hospitalier de l'Université de Montréal (CHUM) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2021 Category: Research Source Type: clinical trials

Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Interventions:   Drug: Rituximab;   Drug: Tocilizumab;   Drug: Abatacept Sponsors:   Assistance Publique - Hôpitaux de Paris;   URC/CIC (Clinical Research Unit) Paris Descartes Necker-Cochin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2021 Category: Research Source Type: clinical trials

Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy
Condition:   Peanut Allergy Interventions:   Drug: Abatacept;   Other: Peanut oral immunotherapy Sponsors:   Philippe Bégin;   Centre hospitalier de l'Université de Montréal (CHUM) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2021 Category: Research Source Type: clinical trials

Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Interventions:   Drug: Rituximab;   Drug: Tocilizumab;   Drug: Abatacept Sponsors:   Assistance Publique - Hôpitaux de Paris;   URC/CIC (Clinical Research Unit) Paris Descartes Necker-Cochin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2021 Category: Research Source Type: clinical trials

Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy
Condition:   Peanut Allergy Interventions:   Drug: Abatacept;   Other: Peanut oral immunotherapy Sponsors:   Philippe Bégin;   Centre hospitalier de l'Université de Montréal (CHUM) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2021 Category: Research Source Type: clinical trials

Abatacept s.c. for aGVHD Prevention in Haplo-HCT
Conditions:   Abatacept;   Acute-graft-versus-host Disease;   Haplo-identical HCT;   Prevention Interventions:   Drug: Lower dose of abatacept;   Drug: Higher dose of abatacept Sponsor:   The First Affiliated Hospital of Soochow University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2020 Category: Research Source Type: clinical trials